Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Aspirin gegen das Altern? : für wen und wieviel?
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 167600
Author(s) Oelz, O; Meier, P J
Author(s) at UniBasel Meier-Abt, Peter J.
Year 1990
Title Aspirin gegen das Altern? : für wen und wieviel?
Journal Therapeutische Umschau
Volume 47
Number 8
Pages 648-52
Abstract

Aspirin has been successfully used in the secondary prophylaxis of myocardial infarction, cerebral vascular events and peripheral arterial disease. Regular aspirin intake may further be beneficial in asymptomatic healthy male with cardiovascular risk factors over the age of 50. There is no good evidence that aspirin prevents the development of atherosclerosis and thromboembolic events in healthy individuals.

Publisher Hans Huber
ISSN/ISBN 0040-5930
edoc-URL http://edoc.unibas.ch/dok/A5261774
Full Text on edoc No
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/2218966
ISI-Number WOS:A1990DW95100004
Document type (ISI) Journal Article
Additional Information Variant title: >>L'<
 
   

MCSS v5.8 PRO. 0.326 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024